← k3vl4r
Log inGet started →

INCY (Incyte) Price Forecast

AI-generated price forecast for Incyte (INCY) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads INCY as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 116.74. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

116.74

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

INCY forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+16.32%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called INCY's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest INCY news

From the market-news feed the forecasts are read against.

  • Povofortay® (povorcitinib) Approved in Europe as the First Once-Daily Oral Treatment for Adults with Moderate to Severe Hidradenitis Suppurativa · Yahoo · Nov 16
  • Incyte Has Decided Not To Proceed With The Planned Phase 3 MAESTRA-3 Study Evaluating INCB123667; Company Does Not Expect This Determination To Affect Its Financial Guidance Or Its Previously Disclosed Long-term Outlook · Benzinga · Nov 13
  • How Incyte Trial And New Cancer Data Will Impact Natera Stock · Yahoo · Nov 13
  • Natera (NTRA) Following Clinical Momentum Looks Fully Valued To Some · Yahoo · Nov 12
  • What Will Decide Vertex Stock Over The Next Six Months? · Yahoo · Nov 11

🔒

See the full INCY forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

INCY forecast — frequently asked

Will INCY go up?

K3vl4r's calibrated AI forecast currently reads INCY as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the INCY price prediction for 2026?

K3vl4r's model projects INCY toward $139.90 over the next ~4 weeks, a +16.3% move from $120.27. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

NTLABEAMBNTXJAZZPRTAEDITTMDXIOVAGILDBIIBAGIOIRWDNBIXVIR

Will INCY reach…?

Will INCY reach $200.00?Will INCY reach $250.00?Will INCY reach $500.00?

Or see the full INCY price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare INCY

INCY vs NTLAINCY vs BEAMINCY vs BNTXINCY vs JAZZINCY vs PRTAINCY vs EDIT

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.